Chuck W, Shadbolt BF, Nordin F, Subramaniam K, et al. BMI is important in predicting the loss of response in inflammatory bowel disease patients on tumour necrosis factor-alpha inhibitors. Eur J Gastroenterol Hepatol 2022 Mar 29. pii: 00042737-990000000-00002.
PMID: 35352694